Antiovarian antibodies in primary Sjogren’s syndrome

被引:0
|
作者
Kyriaki Euthymiopoulou
Alexios J. Aletras
Panagiota Ravazoula
Anna Niarakis
Dimitris Daoussis
Ioannis Antonopoulos
Stamatis-Nick Liossis
Andrew P. Andonopoulos
机构
[1] University of Patras,Laboratory of Biochemistry, Department of Chemistry, School of Natural Sciences
[2] University of Patras,Department of Pathology, University Hospital of Patras, School of Medicine
[3] University of Patras,Division of Rheumatology of the Department of Medicine, School of Medicine
来源
关键词
Antiovarian antibodies; Sjogren’s syndrome; Autoimmune oophoritis; Premature ovarian failure;
D O I
暂无
中图分类号
学科分类号
摘要
Our study aimed at screening patients with primary Sjogren’s syndrome (pSs) for the presence of antiovarian antibodies (AOAs). Detection of AOAs in patients’ sera was achieved by ELISA, using bovine ovarian extract for coating. Western blot analysis and immunohistochemistry were used to characterize the antibody targets in the extract and to determine their locus on the bovine ovary, respectively. Specific AOAs were detected in 27% of 37 patients (two with premature menopause) and in none of the controls. Immunoreactivity mainly resided in five proteins of the extract with molecular masses 42, 49, 55, 64 and 72 kDa, and it might be attributed to their carbohydrate components. The antibody targets were mainly located in the granulosa and theca interna cells of the follicle, and in the endothelial cells and fibroblasts of corpus luteum. The detection, for the first time, of AOAs in a significant percentage of patients with pSs may suggest autoimmune oophoritis, clinical or subclinical.
引用
收藏
页码:1149 / 1155
页数:6
相关论文
共 50 条
  • [21] Sensitivity and specificity of anti-α-fodrin antibodies in primary Sjogren's syndrome
    Szántó, A
    Csípo, I
    Zeher, M
    JOURNAL OF RHEUMATOLOGY, 2005, 32 (01) : 197 - 197
  • [22] Clinical and laboratory features of primary Sjogren's syndrome associated with anticentromere antibodies
    Chaltsev, B.
    Vasiliev, V.
    Palshina, S.
    Rodionova, E.
    Safonova, T.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (03) : S280 - S281
  • [23] Antibodies against citrullinated alpha enolase peptides in primary Sjogren's syndrome
    Nezos, Adrianos
    Cinoku, Ilir
    Mavragani, Clio P.
    Moutsopoulos, Haralampos M.
    CLINICAL IMMUNOLOGY, 2017, 183 : 300 - 303
  • [24] Antibodies against GnRH and its receptor in patients with primary Sjogren's syndrome
    Mandl, T.
    Roth, B.
    Ohlsson, B.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2014, 43 (04) : 338 - 339
  • [25] Seronegative primary Sjogren's syndrome, a distinct subtype of primary Sjogren's syndrome in Chinese patients
    Lan, Jingying
    Deng, Chaoqiong
    Huang, Heqing
    Rao, Peishi
    Chen, Yangchun
    Shi, Yingying
    Chen, Jie
    Shi, Guixiu
    Liu, Yuan
    Chen, Shiju
    BMC RHEUMATOLOGY, 2024, 8 (01)
  • [26] Methotrexate in primary Sjogren's syndrome
    Skopouli, FN
    Jagiello, P
    Tsifetaki, N
    Moutsopoulos, HM
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1996, 14 (05) : 555 - 558
  • [27] Zidovudine in primary Sjogren's syndrome
    Steinfeld, SD
    Demols, P
    Van Vooren, JP
    Cogan, E
    Appelboom, T
    RHEUMATOLOGY, 1999, 38 (09) : 814 - 817
  • [28] Myocarditis and primary Sjogren's syndrome
    Levin, MD
    Zoet-Nugteren, SK
    Markusse, HM
    LANCET, 1999, 354 (9173): : 128 - 129
  • [29] Myocarditis and primary Sjogren's syndrome
    Yoshioka, K
    Tegoshi, H
    Yoshida, T
    Uoshima, N
    Kasamatsu, Y
    LANCET, 1999, 354 (9194): : 1996 - 1996
  • [30] Targeting primary Sjogren's syndrome
    Odani, Toshio
    Chiorini, John A.
    MODERN RHEUMATOLOGY, 2019, 29 (01) : 70 - 86